Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRB..L Regulatory News (RB.)

  • There is currently no data for RB.

Board Committee Changes

29 Jul 2016 16:45

RNS Number : 7403F
Reckitt Benckiser Group PLC
29 July 2016
 

29 July 2016

RECKITT BENCKISER GROUP PLC

(The "Company" or "RB")

 

BOARD COMMITTEE CHANGES

 

The Company is pleased to announce the following changes to its standing Board Committees and their membership.

New Corporate Responsibility, Sustainability, Ethics and Compliance Committee

On the recommendation of the Nomination Committee, on 28 July 2016 the Board approved the establishment of a new Board committee to be known as the Corporate Responsibility, Sustainability, Ethics and Compliance Committee ("CRSEC Committee") with immediate effect. This new committee will support the Board in fulfilling its duty to safeguard and advance the Company's reputation for responsible and sustainable corporate conduct by reviewing, monitoring and assessing its approach to and management of corporate social responsibility, environmental and sustainability issues and behaviours, ethical conduct and regulatory compliance.

The CRSEC Committee will be chaired by Pam Kirby, and Adrian Bellamy and Nicandro Durante have been appointed as committee members. The CRSEC Committee will meet at least three times per year and at such other times as required. 

The Committee's terms of reference will be available on the Company's website at www.rb.com

Nomination Committee Membership

The Nomination Committee also recommended, and the Board approved, the appointment of Pam Kirby to the Nomination Committee with immediate effect. 

This disclosure is made in accordance with paragraph 9.6.11 of the Financial Conduct Authority's Listing rules.

 

For further Information:

Chris LoganCompany Secretary+44 (0) 1753 217 800

 

Richard Joyce

SVP, Investor Relations, Communications & External Affairs

+44 (0)1753 217 800

 

 

About RB:

 

RB* is the world's leading consumer health and hygiene company. The company has operations in over 60 countries, with headquarters in London, Dubai and Amsterdam, and sales in most countries across the globe. The company employs approximately c. 37,000 people worldwide.

Inspired by a purpose to deliver innovative solutions for healthier lives and happier homes, RB is in the top 20 companies listed on the London Stock Exchange. We are the global No 1 or No 2 in the majority of our fast-growing categories, driven by an exceptional focus on innovation. Our health, hygiene and home portfolio is led by our global Powerbrands including Nurofen, Strepsils, Gaviscon, Mucinex, Durex, Scholl, Clearasil, Lysol, Dettol, Veet, Harpic, Cillit Bang, Mortein, Finish, Vanish, Calgon, Air Wick, Woolite and French's. Our Powerbrands represent 80% of net revenue.

 

RB is redefining the world of consumer health and hygiene. Our people and unique culture are at the heart of our success. We have a drive for achievement and a passion to outperform wherever we focus, including sustainability where we are targeting a 1/3 reduction in water impact, 1/3 reduction in carbon and 1/3 of net revenue from more sustainable products. We are proud to be Save the Children's largest global partner, with a new vision to radically reduce one of the world's largest killers of under 5s, diarrhoea. 

 

For more information visit www.rb.com

 

*RB is the trading name of the Reckitt Benckiser group of companies

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOASEEFIUFMSELW
Date   Source Headline
1st Dec 20179:00 amRNSTotal Voting Rights
8th Nov 20171:50 pmRNSDirector/PDMR Shareholding
7th Nov 20173:57 pmRNSHolding(s) in Company
2nd Nov 20177:00 amRNSDirector/PDMR Shareholding - Replacement
1st Nov 20175:52 pmRNSDirector/PDMR Shareholding
1st Nov 20179:00 amRNSTotal Voting Rights
18th Oct 20177:00 amRNSQ3 2017: Trading Update
6th Oct 20175:42 pmRNSDirector/PDMR Shareholding
3rd Oct 20174:38 pmRNSDirector/PDMR Shareholding
3rd Oct 20179:50 amRNSHolding(s) in Company
2nd Oct 20173:46 pmRNSTotal Voting Rights
19th Sep 20177:00 amRNSDirectorate Change
14th Sep 20171:31 pmRNSHolding(s) in Company
4th Sep 20172:00 pmRNSDirector/PDMR Shareholding
1st Sep 20179:17 amRNSTotal Voting Rights
18th Aug 20177:00 amRNSCompletion of Sale of Food Business to McCormick
2nd Aug 201712:25 pmRNSDirector/PDMR Shareholding
1st Aug 20173:27 pmRNSTotal Voting Rights
24th Jul 20177:06 amRNSReckitt battles tough markets and disappointing Mead margins
24th Jul 20177:00 amRNSHalf-year Report
19th Jul 20177:00 amRNSRB Sale of Food Business to McCormick
6th Jul 20177:00 amRNSCyber attack update and estimated financial effect
3rd Jul 20179:29 amRNSTotal Voting Rights
23rd Jun 201711:00 amRNSPublication of a Prospectus - Replacement
22nd Jun 20175:26 pmRNSPublication of a Prospectus
22nd Jun 20174:19 pmRNSDirector/PDMR Shareholding
22nd Jun 201710:08 amRNSDirector/PDMR Shareholding
22nd Jun 20177:00 amRNSIssue of Debt
19th Jun 201711:47 amRNSDirector/PDMR Shareholding
15th Jun 20171:58 pmRNSCompletion of MJN Acquisition
12th Jun 20172:38 pmRNSExpected Completion Date of MJN Acquisition
1st Jun 20174:23 pmRNSDirector/PDMR Shareholding
1st Jun 201710:12 amRNSTotal Voting Rights
31st May 20174:58 pmRNSResult of General Meeting
31st May 20173:42 pmRNSDirector/PDMR Shareholding
26th May 20174:06 pmRNSDirector/PDMR Shareholding
22nd May 20172:44 pmRNSDirector/PDMR Shareholding
22nd May 20171:20 pmRNSDirector/PDMR Shareholding
16th May 20175:33 pmRNSDirector/PDMR Shareholding
16th May 20175:27 pmRNSDirector/PDMR Shareholding
12th May 20173:27 pmRNSDirector/PDMR Shareholding
8th May 20176:15 pmRNSDirector/PDMR Shareholding
5th May 20174:21 pmRNSCircular to Shareholders and Notice of GM
5th May 201712:07 pmRNSOutcome of Audit Tender
4th May 20176:16 pmRNSResult of AGM
2nd May 20179:00 amRNSTotal Voting Rights
21st Apr 20177:00 amRNSQ1 2017 : Trading Update
3rd Apr 20177:00 amRNSStrategic Review of Food Business
31st Mar 20174:45 pmRNSTotal Voting Rights
31st Mar 20179:00 amRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.